WuXi Biologics
Nearly 20 years’ experience
Shanghai Kanda, Celgen, AME, Eli Lilly, Merck
First ISPE Board Member from Asia
University of Delaware (Ph.D.), Tsinghua University (B.S.)
This person is not in any offices
WuXi Biologics
16 followers
WuXi Biologics, a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing.